Skip to content
healthcare.dev
Get a free key

Cisatracurium Besylate

NDC 70069-161, Cisatracurium Besylate, injection, from Somerset Therapeutics, LLC.

Product NDC
70069-161
Status
Listed
Labeler
Somerset Therapeutics, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209132
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70069-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
70069-161-01700690161011 VIAL in 1 CARTON (70069-161-01) / 10 mL in 1 VIAL
70069-161-107006901611010 VIAL, MULTI-DOSE in 1 CARTON (70069-161-10) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/23daa1f8-2a07-449d-97a6-11efdb0b9836

Use it

Look up 70069-161 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70069-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70069-161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.